(R)-Zunsemetinib

(R)-Zunsemetinib Structure
(R)-Zunsemetinib structure
Common Name (R)-Zunsemetinib
CAS Number 1640282-44-5 Molecular Weight 513.92
Density N/A Boiling Point N/A
Molecular Formula C25H22ClF2N5O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of (R)-Zunsemetinib


(R)-Zunsemetinib is the inactive isomer of Zunsemetinib (HY-139553), and can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases[1].

 Names

Name (R)-Zunsemetinib

 (R)-Zunsemetinib Biological Activity

Description (R)-Zunsemetinib is the inactive isomer of Zunsemetinib (HY-139553), and can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases[1].
Related Catalog
References

[1]. Zunsemetinib (ATI-450) – Investigational oral MK2 pathway inhibitor

[2]. Aclaris Therapeutics Announces ATI-450 (MK2 pathway Inhibitor) publication in Journal of Experimental Medicine

[3]. Wang C, et al. Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals. J Exp Med. 2018;215(5):1315-1325.  

 Chemical & Physical Properties

Molecular Formula C25H22ClF2N5O3
Molecular Weight 513.92
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.